◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Helix BioPharma Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Total Revenue -- 0.00 0.00 0.00 0.00
Operating Revenue -- 0.00 0.00 0.00 0.00
Selling General And Administration 1.8M 3.3M 1.0M 1.5M --
General And Administrative Expense 1.8M 3.3M 1.0M 1.5M --
Research And Development -- 6.0M 5.3M 4.5M 5.9M
Depreciation And Amortization In Income Statement -- -- -- 0.00 3,000
Other Operating Expenses -- 687,000 746,000 901,000 1.6M
Operating Expense -- 9.2M 6.3M 6.0M 9.1M
Operating Income -- -9.2M -6.3M -6.0M -9.1M
EBIT -- -9.3M -6.3M -6.5M -9.6M
Interest Expense -- 7,000 14,000 18,000 15,000
Interest Expense Non Operating -- 7,000 14,000 18,000 15,000
Interest Income -- 31,000 47,000 4,000 0.00
Interest Income Non Operating -- 31,000 47,000 4,000 0.00
Net Interest Income -- 24,000 33,000 -14,000 -353,000
Other Income Expense -- -49,000 3,000 -510,000 -90,000
Other Non Operating Income Expenses -- -- -- -501,000 -142,000
Special Income Charges -- 0.00 5,000 0.00 --
Gain On Sale Of Security -- -49,000 -2,000 -9,000 52,000
Pretax Income -- -9.3M -6.3M -6.6M -9.6M
Tax Effect Of Unusual Items -31,200 -12,740 780.00 -2,327 --
Net Income From Continuing And Discontinued Operation -- -9.3M -6.3M -6.6M -8.0M
Net Income From Continuing Operation Net Minority Interest -- -9.3M -6.3M -6.6M -9.6M
Net Income Including Noncontrolling Interests -- -9.3M -6.3M -6.6M -8.0M
Minority Interests -- -- -- -- 0.00
Net Income Common Stockholders -- -9.3M -6.3M -6.6M -8.0M
Net Income -- -9.3M -6.3M -6.6M -8.0M
EBITDA -- -9.2M -6.3M -6.5M -9.4M
Normalized EBITDA -- -9.2M -6.3M -6.5M -9.4M
Reconciled Depreciation -- 14,000 13,000 12,000 199,000
Basic EPS -0.09 -0.21 -0.16 -0.20 --
Diluted EPS -0.09 -0.21 -0.16 -0.20 --
Basic Average Shares 55.7M 44.5M 38.6M 29.9M --
Diluted Average Shares 55.7M 44.5M 38.6M 29.9M --
Total Unusual Items -- -49,000 3,000 -9,000 52,000
Total Unusual Items Excluding Goodwill -- -49,000 3,000 -9,000 52,000
Tax Rate For Calcs 0.26 0.26 0.26 0.26 --
Normalized Income -5.1M -9.2M -6.3M -6.6M --
Depreciation Amortization Depletion Income Statement -- -- -- 0.00 3,000
Depreciation Income Statement -- -- -- 0.00 3,000
Diluted NI Availto Com Stockholders -- -9.3M -6.3M -6.6M -8.0M
Gain On Sale Of Ppe -- 0.00 5,000 0.00 --
Net Income Continuous Operations -- -9.3M -6.3M -6.6M -9.6M
Net Income Discontinuous Operations -- -- -- 0.00 1.5M
Net Non Operating Interest Income Expense -- 24,000 33,000 -14,000 -353,000
Other Gand A 1.5M 687,000 746,000 901,000 --
Salaries And Wages -- 2.6M 299,000 595,000 1.7M
Total Expenses -- 9.2M 6.3M 6.0M 9.1M
Total Other Finance Cost -- -- -- -- 338,000
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Cash And Cash Equivalents -- 1.1M 808,000 3.3M 3.6M
Cash Cash Equivalents And Short Term Investments -- 1.1M 808,000 3.3M 3.6M
Cash Financial -- 1.1M 808,000 3.3M 3.6M
Receivables -- 54,000 62,000 279,000 353,000
Prepaid Assets -- 321,000 126,000 164,000 100,000
Other Current Assets -- -- -- -1,000 --
Current Assets -- 1.5M 996,000 3.7M 4.0M
Gross PPE -- 1.8M 1.8M 1.8M 1.8M
Accumulated Depreciation -- -1.8M -1.8M -1.8M -1.8M
Net PPE -- 33,000 33,000 35,000 47,000
Other Non Current Assets -- -- -- 1,000 --
Total Non Current Assets -- 33,000 33,000 35,000 47,000
Total Assets -- 1.5M 1.0M 3.7M 4.1M
Current Debt -- -- -- 2.5M 2.0M
Current Debt And Capital Lease Obligation -- -- -- 2.5M 2.0M
Accounts Payable -- 855,000 493,000 599,000 1.5M
Payables -- 855,000 493,000 599,000 1.5M
Payables And Accrued Expenses -- 1.6M 876,000 944,000 1.8M
Current Accrued Expenses -- 724,000 383,000 345,000 380,000
Other Current Liabilities -- -- 998,000 -1,000 --
Current Liabilities -- 1.6M 1.9M 3.4M 3.9M
Long Term Debt -- -- -- -- 1.6M
Long Term Debt And Capital Lease Obligation -- -- -- -- 1.6M
Total Non Current Liabilities Net Minority Interest -- 0.00 0.00 0.00 1.6M
Total Liabilities Net Minority Interest -- 1.6M 1.9M 3.4M 5.5M
Common Stock -- 158.6M 152.1M 147.5M 139.7M
Capital Stock -- 158.6M 152.1M 147.5M 139.7M
Additional Paid In Capital -- 47.4M 44.1M 37.6M 27.9M
Retained Earnings -- -210.7M -201.4M -195.1M -188.6M
Common Stock Equity -- -90,000 -845,000 319,000 -1.4M
Stockholders Equity -- -90,000 -845,000 319,000 -1.4M
Total Equity Gross Minority Interest -- -90,000 -845,000 319,000 -1.4M
Total Capitalization -- -90,000 -845,000 319,000 191,000
Net Tangible Assets -- -90,000 -845,000 319,000 -1.4M
Tangible Book Value -- -90,000 -845,000 319,000 -1.4M
Working Capital -- -123,000 -878,000 283,000 144,000
Invested Capital -- -90,000 -845,000 2.8M 2.2M
Total Debt -- -- -- 2.5M 3.6M
Net Debt -- -- -- -- 47,000
Share Issued -- 49.0M 40.0M 34.4M 28.2M
Ordinary Shares Number -- 49.0M 40.0M 34.4M 28.2M
Leases -- 359,000 359,000 359,000 359,000
Machinery Furniture Equipment -- 111,000 109,000 99,000 99,000
Other Current Borrowings -- -- -- 2.5M 2.0M
Other Equity Interest -- 4.6M 4.4M 10.3M 19.6M
Other Properties -- 1.4M 1.4M 1.4M 1.4M
Other Receivables -- 15,000 15,000 76,000 135,000
Properties -- 0.00 0.00 0.00 0.00
Taxes Receivable -- 39,000 47,000 203,000 218,000
Line Item FY 2025Jul 31, 2025 FY 2024Jul 31, 2024 FY 2023Jul 31, 2023 FY 2022Jul 31, 2022 FY 2021Jul 31, 2021
Operating Cash Flow -- -5.2M -5.5M -6.5M -9.3M
Cash Flow From Continuing Operating Activities -- -5.2M -5.5M -6.5M -8.7M
Depreciation And Amortization -- 14,000 13,000 12,000 199,000
Depreciation Amortization Depletion -- 14,000 13,000 12,000 199,000
Stock Based Compensation -- 3.5M 569,000 425,000 663,000
Change In Working Capital -- 485,000 185,000 -892,000 -54,000
Changes In Account Receivables -- 8,000 217,000 74,000 -173,000
Change In Receivables -- 8,000 217,000 74,000 -173,000
Change In Payables And Accrued Expense -- 671,000 -69,000 -902,000 129,000
Change In Payable -- -- -106,000 -867,000 50,000
Other Non Cash Items -- -- -- -1,000 142,000
Capital Expenditure -- -14,000 -10,000 -- --
Purchase Of PPE -- -14,000 -10,000 0.00 --
Net PPE Purchase And Sale -- -14,000 -5,000 0.00 --
Sale Of Business -- -- -- 0.00 2.0M
Investing Cash Flow -- -14,000 -5,000 0.00 2.0M
Cash Flow From Continuing Investing Activities -- -14,000 -5,000 0.00 2.0M
Issuance Of Debt -- -- -- 0.00 3.2M
Repayment Of Debt -- 0.00 -2.1M 0.00 -158,000
Net Issuance Payments Of Debt -- 0.00 -2.1M 0.00 3.0M
Issuance Of Capital Stock -- 5.5M 4.2M 3.0M 3.6M
Net Common Stock Issuance -- 5.5M 4.2M 3.0M 3.6M
Financing Cash Flow -- 5.5M 3.1M 6.2M 6.6M
Cash Flow From Continuing Financing Activities -- 5.5M 3.1M 6.2M 6.6M
Effect Of Exchange Rate Changes -- -- 0.00 -9,000 52,000
Changes In Cash -- 273,000 -2.4M -304,000 -722,000
Beginning Cash Position -- 808,000 3.3M 3.6M 4.2M
End Cash Position -- 1.1M 808,000 3.3M 3.6M
Free Cash Flow -- -5.2M -5.5M -6.5M -9.3M
Cash From Discontinued Operating Activities -- -- -- 0.00 -628,000
Change In Account Payable -- -- -106,000 -867,000 50,000
Change In Accrued Expense -- -- 38,000 -35,000 79,000
Change In Prepaid Assets -- -194,000 37,000 -64,000 -10,000
Common Stock Issuance -- 5.5M 4.2M 3.0M 3.6M
Depreciation -- 14,000 13,000 12,000 199,000
Earnings Losses From Equity Investments -- -- -- 0.00 -1.5M
Gain Loss On Sale Of PPE -- 0.00 -5,000 0.00 --
Long Term Debt Issuance -- -- -- 0.00 3.2M
Long Term Debt Payments -- -- -- 0.00 -158,000
Net Business Purchase And Sale -- -- -- 0.00 2.0M
Net Foreign Currency Exchange Gain Loss -- 31,000 2,000 9,000 -52,000
Net Income From Continuing Operations -- -9.3M -6.3M -6.6M -8.0M
Net Long Term Debt Issuance -- -- -- 0.00 3.0M
Net Other Financing Charges -- -- 998,000 -- --
Net Short Term Debt Issuance -- 0.00 -2.1M 0.00 --
Operating Gains Losses -- 31,000 -3,000 9,000 -1.6M
Proceeds From Stock Option Exercised -- -- 0.00 3.2M 0.00
Sale Of PPE -- 0.00 5,000 0.00 --
Short Term Debt Payments -- 0.00 -2.1M 0.00 --
Unrealized Gain Loss On Investment Securities -- -- 0.00 501,000 142,000
NEWS
Loading news...
TRENDING
Loading...